TRVI vs. ARKF

Last updated Aug 4, 2026

TRVI (Trevi Therapeutics, Inc.) is a stock, while ARKF (ARK Fintech Innovation ETF) is Blockchain fund actively managed by ARK. Over the past 5 years, TRVI returned 56.45%/yr vs -4.94%/yr for ARKF. Their 0.21 correlation means their historical movements had little consistent relationship.

Performance

TRVI vs. ARKF - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Trevi Therapeutics, Inc. (TRVI) and ARK Fintech Innovation ETF (ARKF). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, TRVI achieves a 42.97% return, which is significantly higher than ARKF's -14.89% return.

TRVI

• 1D: -1.92%
• 1M: -0.17%
• 6M: 63.32%
• YTD: 42.97%
• 1Y: 144.20%
• 3Y*: 97.32%
• 5Y*: 56.45%
• 10Y*: —
• ALL TIME*: 9.14%

ARKF

• 1D: 2.24%
• 1M: -1.05%
• 6M: -4.84%
• YTD: -14.89%
• 1Y: -20.38%
• 3Y*: 22.73%
• 5Y*: -4.94%
• 10Y*: —
• ALL TIME*: 10.02%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison

Position	Avg. Volume Value (2W)	Avg. Volume Value (1M)	Avg. Volume Value (3M)
ARKF ARK Fintech Innovation ETF	$6.22M	$5.36M	$7.06M
TRVI Trevi Therapeutics, Inc.	$29.66M	$45.48M	$35.03M

TRVI vs. ARKF - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019
TRVI Trevi Therapeutics, Inc.	42.97%	203.88%	207.46%	-30.57%	146.74%	-67.68%	-35.47%	-60.53%
ARKF ARK Fintech Innovation ETF	-14.89%	28.67%	34.34%	93.27%	-65.07%	-17.82%	108.03%	6.91%

Correlation

The correlation between TRVI and ARKF is 0.24, which is low. Their historical price movements had little consistent relationship.

	Correlation
Correlation (1Y) Focuses on recent behavior, but can change the most.	0.24
Correlation (3Y) Balances recent behavior with more history.	0.22
Correlation (5Y) Shows whether the relationship held over a longer period.	0.24
Correlation (All Time) Calculated using the full available price history since May 7, 2019	0.21

Return for Risk

TRVI vs. ARKF — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

TRVI

TRVI Risk / Return Rank: 92
TRVI Sharpe Ratio Rank: 94
TRVI Sortino Ratio Rank: 89
TRVI Omega Ratio Rank: 89
TRVI Calmar Ratio Rank: 94
TRVI Martin Ratio Rank: 92

ARKF

ARKF Risk / Return Rank: 5
ARKF Sharpe Ratio Rank: 4
ARKF Sortino Ratio Rank: 5
ARKF Omega Ratio Rank: 5
ARKF Calmar Ratio Rank: 5
ARKF Martin Ratio Rank: 5

The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

TRVI vs. ARKF - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Trevi Therapeutics, Inc. (TRVI) and ARK Fintech Innovation ETF (ARKF). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	TRVI	ARKF	Difference
Sharpe ratio: Return per unit of total volatility	2.29	-0.61	+2.89
Sortino ratio: Return per unit of downside risk	2.70	-0.68	+3.39
Omega ratio: Gain probability vs. loss probability	1.35	0.92	+0.43
Calmar ratio: Return relative to maximum drawdown	4.92	-0.53	+5.45
Martin ratio: Return relative to average drawdown	11.54	-0.85	+12.39

TRVI vs. ARKF - Sharpe Ratio Comparison

The current TRVI Sharpe Ratio is 2.29, which is higher than the ARKF Sharpe Ratio of -0.61. The chart below compares the historical Sharpe Ratios of TRVI and ARKF, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

TRVI vs. ARKF - Drawdown Comparison

The maximum TRVI drawdown since its inception was -95.45%, which is greater than ARKF's maximum drawdown of -78.63%. Use the drawdown chart below to compare losses from any high point for TRVI and ARKF.

Drawdown Indicators

	TRVI	ARKF	Difference
Max Drawdown Largest peak-to-trough decline	-95.45%	-78.63%	-16.82%
Max Drawdown (1Y) Largest decline over 1 year	-29.50%	-38.50%	+9.00%
Max Drawdown (3Y) Largest decline over 3 years	-55.99%	-38.50%	-17.49%
Max Drawdown (5Y) Largest decline over 5 years	-78.10%	-75.30%	-2.80%
Current Drawdown Current decline from peak	-8.21%	-36.20%	+27.99%
Average Drawdown Average peak-to-trough decline	-60.44%	-34.98%	-25.46%
Ulcer Index Depth and duration of drawdowns from previous peaks	12.55%	23.90%	-11.35%

Volatility

TRVI vs. ARKF - Volatility Comparison

Trevi Therapeutics, Inc. (TRVI) has a higher volatility of 25.46% compared to ARK Fintech Innovation ETF (ARKF) at 8.61%. This indicates that TRVI's price experiences larger fluctuations and is considered to be riskier than ARKF based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	TRVI	ARKF	Difference
Volatility (1M) Calculated over the trailing 1-month period	25.46%	8.61%	+16.85%
Volatility (6M) Calculated over the trailing 6-month period	42.50%	26.06%	+16.44%
Volatility (1Y) Calculated over the trailing 1-year period	63.56%	33.79%	+29.77%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	88.79%	43.01%	+45.78%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	98.96%	39.62%	+59.34%

Dividends

TRVI vs. ARKF - Dividend Comparison

TRVI has not paid dividends to shareholders, while ARKF's dividend yield for the trailing twelve months is around 0.11%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019
ARKF ARK Fintech Innovation ETF	0.11%	0.09%	0.00%	0.00%	0.00%	0.00%	0.37%	1.25%
TRVI Trevi Therapeutics, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both TRVI and ARKF in my portfolio?

TRVI and ARKF have a correlation of 0.24, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, TRVI or ARKF?

TRVI has higher volatility (25.46%) compared to ARKF (8.61%). In terms of maximum drawdown, TRVI dropped -95.45% vs ARKF's -78.63%.

Which has better risk-adjusted returns?

TRVI currently has the higher Sharpe Ratio (2.29 vs -0.61), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.